A Novel Bioactivation Pathway for 2-[2-(2,6-Dichlorophenyl)aminophenyl]ethanoic Acid (Diclofenac) Initiated by Cytochrome P450-Mediated Oxidative Decarboxylation
Authors:
- Mark P. GrilloMGMark P. Grillo
- Ji MaJMJi Ma
- Yohannes TefferaYTYohannes Teffera
- Daniel J. WaldonDWDaniel J. Waldon
- 1 September 2008
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 36 (9) , 1740-1744
Abstract
Diclofenac (2-[2-(2,6-dichlorophenyl)aminophenyl]ethanoic acid), a nonsteroidal antiinflammatory drug, undergoes bioactivation by cytochrome P450 oxidation to chemically reactive metabolites that are capable of reacting with endogenous nucleophiles such as glutathione (GSH) and proteins and that may play a role in the idiosyncratic hepatotoxicity associated with the drug. Here, we investigated the ability of diclofenac to be metabolized to 2-(2,6-dichloro-phenylamino)benzyl-S-thioether glutathione (DPAB-SG) in incubations with rat liver microsomes (RLMs) and human liver microsomes (HLMs) fortified with NADPH and GSH. Thus, after incubation of diclofenac (50 μM) with liver microsomes (1 mg protein/ml), the presence of DPAB-SG was detected in both RLM and HLM incubation extracts by liquid chromatography-tandem mass spectrometry techniques. The formation of DPAB-SG was NADPH-, concentration-, and time-dependent. Coincubation of diclofenac (10 μM) with ketoconazole (1 μM), an inhibitor of cytochrome P450 (P450) 3A4, with HLMs led to a 75% decrease in DPAB-SG formation. However, in contrast, coincubation with the P450 2C9 inhibitor sulfaphenazole (10 μM) or the P450 2D6 inhibitor quinidine (40 μM) led to a 1.9- and 1.6-fold increase in DPAB-SG production, respectively. From these data, we propose that P450 3A4 mediates the oxidative decarboxylation of diclofenac, resulting in the formation of a transient benzylic carbon-centered free radical intermediate that partitions between elimination (o-imine methide production) and recombination (alcohol formation) pathways. The benzyl alcohol intermediate, which was not analyzed for in the present studies, if formed could undergo dehydration to provide a reactive o-imine methide species. The o-imine methide intermediate then is proposed to react covalently with GSH, forming DPAB-SG.Keywords
This publication has 8 references indexed in Scilit:
- Identification of a Novel Glutathione Conjugate of Diclofenac by LTQOrbitrapDrug Metabolism Letters, 2008
- Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicityToxicology and Applied Pharmacology, 2003
- The Metabolism of Diclofenac - Enzymology and Toxicology PerspectivesCurrent Drug Metabolism, 2003
- Diclofenac-Induced Inactivation of CYP3A4 and Its Stimulation by QuinidineDrug Metabolism and Disposition, 2002
- Cytochrome P450 3A4-Mediated Interaction of Diclofenac and QuinidineDrug Metabolism and Disposition, 2000
- Studies on Cytochrome P-450-Mediated Bioactivation of Diclofenac in Rats and in Human Hepatocytes: Identification of Glutathione Conjugated MetabolitesDrug Metabolism and Disposition, 1999
- Roles of Human Hepatic Cytochrome P450s 2C9 and 3A4 in the Metabolic Activation of DiclofenacChemical Research in Toxicology, 1999
- Application of chemical cytochrome P-450 model systems to studies on drug metabolism—VIII. Novel metabolism of carboxylic acids via oxidative decarboxylationBioorganic & Medicinal Chemistry, 1995